InfuSystem (NYSE:INFU) Director Paul Andrew Gendron Acquires 5,000 Shares

InfuSystem Holdings, Inc. (NYSE:INFU) Director Paul Andrew Gendron bought 5,000 shares of the stock in a transaction that occurred on Friday, May 8th. The shares were purchased at an average price of $8.88 per share, with a total value of $44,400.00. Following the purchase, the director owned 70,000 shares of the company’s stock, valued at approximately $621,600. This represents a 7.69% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website.

InfuSystem Stock Down 2.5%

NYSE:INFU traded down $0.21 during trading hours on Tuesday, hitting $8.16. The company’s stock had a trading volume of 244,052 shares, compared to its average volume of 135,464. InfuSystem Holdings, Inc. has a 52-week low of $5.08 and a 52-week high of $11.04. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $164.76 million, a P/E ratio of 136.01 and a beta of 1.49. The stock has a fifty day moving average of $9.67 and a 200-day moving average of $9.21.

Wall Street Analysts Forecast Growth

Separately, Roth Mkm restated a “buy” rating and set a $15.00 target price (up from $14.00) on shares of InfuSystem in a research note on Tuesday, February 24th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $15.00.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in INFU. Hsbc Holdings PLC lifted its stake in InfuSystem by 5.7% in the first quarter. Hsbc Holdings PLC now owns 30,097 shares of the company’s stock valued at $281,000 after buying an additional 1,619 shares during the last quarter. Geode Capital Management LLC grew its position in shares of InfuSystem by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 218,123 shares of the company’s stock worth $1,958,000 after acquiring an additional 1,831 shares during the last quarter. HighTower Advisors LLC increased its holdings in shares of InfuSystem by 13.8% in the 4th quarter. HighTower Advisors LLC now owns 21,061 shares of the company’s stock valued at $189,000 after acquiring an additional 2,561 shares during the period. Integrated Quantitative Investments LLC raised its position in InfuSystem by 6.9% in the 4th quarter. Integrated Quantitative Investments LLC now owns 41,484 shares of the company’s stock valued at $372,000 after purchasing an additional 2,684 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd raised its position in InfuSystem by 25.8% in the 4th quarter. Dynamic Technology Lab Private Ltd now owns 13,724 shares of the company’s stock valued at $123,000 after purchasing an additional 2,811 shares during the last quarter. Institutional investors and hedge funds own 71.13% of the company’s stock.

About InfuSystem

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.